Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Total article views   HTML views PDF downloads Totals
5,470 Dovepress* 4,976+ 631 5,607
PubMed Central* 494 151 645
Totals 5,470 782 6,252
*Since 22 April 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar